[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Buprenorphine Hydrochloride Injection Market Growth 2023-2029

March 2023 | 104 pages | ID: GB63E2AB9280EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Buprenorphine hydrochloride injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate.

LPI (LP Information)' newest research report, the “Buprenorphine Hydrochloride Injection Industry Forecast” looks at past sales and reviews total world Buprenorphine Hydrochloride Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Buprenorphine Hydrochloride Injection sales for 2023 through 2029. With Buprenorphine Hydrochloride Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Buprenorphine Hydrochloride Injection industry.

This Insight Report provides a comprehensive analysis of the global Buprenorphine Hydrochloride Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Buprenorphine Hydrochloride Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Buprenorphine Hydrochloride Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Buprenorphine Hydrochloride Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Buprenorphine Hydrochloride Injection.

The global Buprenorphine Hydrochloride Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Buprenorphine Hydrochloride Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Buprenorphine Hydrochloride Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Buprenorphine Hydrochloride Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Buprenorphine Hydrochloride Injection players cover Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs and Sun Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Buprenorphine Hydrochloride Injection market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • 0.3mg / mL
  • 0.3mg / mL
Segmentation by application
  • Analgesic
  • Opioid Antagonist
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Siegfried
  • Sanofi
  • Johnson Matthey
  • Mallinckrodt
  • Noramco
  • Unichemlabs
  • Arevipharma
  • Resonance-labs
  • Sun Pharma
  • Rusan Pharma
  • Micro Orgo Chem
  • Faranshimi
  • Teva
Key Questions Addressed in this Report

What is the 10-year outlook for the global Buprenorphine Hydrochloride Injection market?

What factors are driving Buprenorphine Hydrochloride Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Buprenorphine Hydrochloride Injection market opportunities vary by end market size?

How does Buprenorphine Hydrochloride Injection break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Buprenorphine Hydrochloride Injection Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Buprenorphine Hydrochloride Injection by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Buprenorphine Hydrochloride Injection by Country/Region, 2018, 2022 & 2029
2.2 Buprenorphine Hydrochloride Injection Segment by Type
  2.2.1 0.3mg / mL
  2.2.2 0.3mg / mL
2.3 Buprenorphine Hydrochloride Injection Sales by Type
  2.3.1 Global Buprenorphine Hydrochloride Injection Sales Market Share by Type (2018-2023)
  2.3.2 Global Buprenorphine Hydrochloride Injection Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Buprenorphine Hydrochloride Injection Sale Price by Type (2018-2023)
2.4 Buprenorphine Hydrochloride Injection Segment by Application
  2.4.1 Analgesic
  2.4.2 Opioid Antagonist
2.5 Buprenorphine Hydrochloride Injection Sales by Application
  2.5.1 Global Buprenorphine Hydrochloride Injection Sale Market Share by Application (2018-2023)
  2.5.2 Global Buprenorphine Hydrochloride Injection Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Buprenorphine Hydrochloride Injection Sale Price by Application (2018-2023)

3 GLOBAL BUPRENORPHINE HYDROCHLORIDE INJECTION BY COMPANY

3.1 Global Buprenorphine Hydrochloride Injection Breakdown Data by Company
  3.1.1 Global Buprenorphine Hydrochloride Injection Annual Sales by Company (2018-2023)
  3.1.2 Global Buprenorphine Hydrochloride Injection Sales Market Share by Company (2018-2023)
3.2 Global Buprenorphine Hydrochloride Injection Annual Revenue by Company (2018-2023)
  3.2.1 Global Buprenorphine Hydrochloride Injection Revenue by Company (2018-2023)
  3.2.2 Global Buprenorphine Hydrochloride Injection Revenue Market Share by Company (2018-2023)
3.3 Global Buprenorphine Hydrochloride Injection Sale Price by Company
3.4 Key Manufacturers Buprenorphine Hydrochloride Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Buprenorphine Hydrochloride Injection Product Location Distribution
  3.4.2 Players Buprenorphine Hydrochloride Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR BUPRENORPHINE HYDROCHLORIDE INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Buprenorphine Hydrochloride Injection Market Size by Geographic Region (2018-2023)
  4.1.1 Global Buprenorphine Hydrochloride Injection Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Buprenorphine Hydrochloride Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Buprenorphine Hydrochloride Injection Market Size by Country/Region (2018-2023)
  4.2.1 Global Buprenorphine Hydrochloride Injection Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Buprenorphine Hydrochloride Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Buprenorphine Hydrochloride Injection Sales Growth
4.4 APAC Buprenorphine Hydrochloride Injection Sales Growth
4.5 Europe Buprenorphine Hydrochloride Injection Sales Growth
4.6 Middle East & Africa Buprenorphine Hydrochloride Injection Sales Growth

5 AMERICAS

5.1 Americas Buprenorphine Hydrochloride Injection Sales by Country
  5.1.1 Americas Buprenorphine Hydrochloride Injection Sales by Country (2018-2023)
  5.1.2 Americas Buprenorphine Hydrochloride Injection Revenue by Country (2018-2023)
5.2 Americas Buprenorphine Hydrochloride Injection Sales by Type
5.3 Americas Buprenorphine Hydrochloride Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Buprenorphine Hydrochloride Injection Sales by Region
  6.1.1 APAC Buprenorphine Hydrochloride Injection Sales by Region (2018-2023)
  6.1.2 APAC Buprenorphine Hydrochloride Injection Revenue by Region (2018-2023)
6.2 APAC Buprenorphine Hydrochloride Injection Sales by Type
6.3 APAC Buprenorphine Hydrochloride Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Buprenorphine Hydrochloride Injection by Country
  7.1.1 Europe Buprenorphine Hydrochloride Injection Sales by Country (2018-2023)
  7.1.2 Europe Buprenorphine Hydrochloride Injection Revenue by Country (2018-2023)
7.2 Europe Buprenorphine Hydrochloride Injection Sales by Type
7.3 Europe Buprenorphine Hydrochloride Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Buprenorphine Hydrochloride Injection by Country
  8.1.1 Middle East & Africa Buprenorphine Hydrochloride Injection Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Buprenorphine Hydrochloride Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Buprenorphine Hydrochloride Injection Sales by Type
8.3 Middle East & Africa Buprenorphine Hydrochloride Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Buprenorphine Hydrochloride Injection
10.3 Manufacturing Process Analysis of Buprenorphine Hydrochloride Injection
10.4 Industry Chain Structure of Buprenorphine Hydrochloride Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Buprenorphine Hydrochloride Injection Distributors
11.3 Buprenorphine Hydrochloride Injection Customer

12 WORLD FORECAST REVIEW FOR BUPRENORPHINE HYDROCHLORIDE INJECTION BY GEOGRAPHIC REGION

12.1 Global Buprenorphine Hydrochloride Injection Market Size Forecast by Region
  12.1.1 Global Buprenorphine Hydrochloride Injection Forecast by Region (2024-2029)
  12.1.2 Global Buprenorphine Hydrochloride Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Buprenorphine Hydrochloride Injection Forecast by Type
12.7 Global Buprenorphine Hydrochloride Injection Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Siegfried
  13.1.1 Siegfried Company Information
  13.1.2 Siegfried Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
  13.1.3 Siegfried Buprenorphine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Siegfried Main Business Overview
  13.1.5 Siegfried Latest Developments
13.2 Sanofi
  13.2.1 Sanofi Company Information
  13.2.2 Sanofi Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
  13.2.3 Sanofi Buprenorphine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Sanofi Main Business Overview
  13.2.5 Sanofi Latest Developments
13.3 Johnson Matthey
  13.3.1 Johnson Matthey Company Information
  13.3.2 Johnson Matthey Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
  13.3.3 Johnson Matthey Buprenorphine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Johnson Matthey Main Business Overview
  13.3.5 Johnson Matthey Latest Developments
13.4 Mallinckrodt
  13.4.1 Mallinckrodt Company Information
  13.4.2 Mallinckrodt Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
  13.4.3 Mallinckrodt Buprenorphine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Mallinckrodt Main Business Overview
  13.4.5 Mallinckrodt Latest Developments
13.5 Noramco
  13.5.1 Noramco Company Information
  13.5.2 Noramco Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
  13.5.3 Noramco Buprenorphine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Noramco Main Business Overview
  13.5.5 Noramco Latest Developments
13.6 Unichemlabs
  13.6.1 Unichemlabs Company Information
  13.6.2 Unichemlabs Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
  13.6.3 Unichemlabs Buprenorphine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Unichemlabs Main Business Overview
  13.6.5 Unichemlabs Latest Developments
13.7 Arevipharma
  13.7.1 Arevipharma Company Information
  13.7.2 Arevipharma Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
  13.7.3 Arevipharma Buprenorphine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Arevipharma Main Business Overview
  13.7.5 Arevipharma Latest Developments
13.8 Resonance-labs
  13.8.1 Resonance-labs Company Information
  13.8.2 Resonance-labs Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
  13.8.3 Resonance-labs Buprenorphine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Resonance-labs Main Business Overview
  13.8.5 Resonance-labs Latest Developments
13.9 Sun Pharma
  13.9.1 Sun Pharma Company Information
  13.9.2 Sun Pharma Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
  13.9.3 Sun Pharma Buprenorphine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Sun Pharma Main Business Overview
  13.9.5 Sun Pharma Latest Developments
13.10 Rusan Pharma
  13.10.1 Rusan Pharma Company Information
  13.10.2 Rusan Pharma Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
  13.10.3 Rusan Pharma Buprenorphine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Rusan Pharma Main Business Overview
  13.10.5 Rusan Pharma Latest Developments
13.11 Micro Orgo Chem
  13.11.1 Micro Orgo Chem Company Information
  13.11.2 Micro Orgo Chem Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
  13.11.3 Micro Orgo Chem Buprenorphine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Micro Orgo Chem Main Business Overview
  13.11.5 Micro Orgo Chem Latest Developments
13.12 Faranshimi
  13.12.1 Faranshimi Company Information
  13.12.2 Faranshimi Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
  13.12.3 Faranshimi Buprenorphine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 Faranshimi Main Business Overview
  13.12.5 Faranshimi Latest Developments
13.13 Teva
  13.13.1 Teva Company Information
  13.13.2 Teva Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
  13.13.3 Teva Buprenorphine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.13.4 Teva Main Business Overview
  13.13.5 Teva Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Buprenorphine Hydrochloride Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Buprenorphine Hydrochloride Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 0.3mg / mL
Table 4. Major Players of 0.3mg / mL
Table 5. Global Buprenorphine Hydrochloride Injection Sales by Type (2018-2023) & (Kg)
Table 6. Global Buprenorphine Hydrochloride Injection Sales Market Share by Type (2018-2023)
Table 7. Global Buprenorphine Hydrochloride Injection Revenue by Type (2018-2023) & ($ million)
Table 8. Global Buprenorphine Hydrochloride Injection Revenue Market Share by Type (2018-2023)
Table 9. Global Buprenorphine Hydrochloride Injection Sale Price by Type (2018-2023) & (US$/Kg)
Table 10. Global Buprenorphine Hydrochloride Injection Sales by Application (2018-2023) & (Kg)
Table 11. Global Buprenorphine Hydrochloride Injection Sales Market Share by Application (2018-2023)
Table 12. Global Buprenorphine Hydrochloride Injection Revenue by Application (2018-2023)
Table 13. Global Buprenorphine Hydrochloride Injection Revenue Market Share by Application (2018-2023)
Table 14. Global Buprenorphine Hydrochloride Injection Sale Price by Application (2018-2023) & (US$/Kg)
Table 15. Global Buprenorphine Hydrochloride Injection Sales by Company (2018-2023) & (Kg)
Table 16. Global Buprenorphine Hydrochloride Injection Sales Market Share by Company (2018-2023)
Table 17. Global Buprenorphine Hydrochloride Injection Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Buprenorphine Hydrochloride Injection Revenue Market Share by Company (2018-2023)
Table 19. Global Buprenorphine Hydrochloride Injection Sale Price by Company (2018-2023) & (US$/Kg)
Table 20. Key Manufacturers Buprenorphine Hydrochloride Injection Producing Area Distribution and Sales Area
Table 21. Players Buprenorphine Hydrochloride Injection Products Offered
Table 22. Buprenorphine Hydrochloride Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Buprenorphine Hydrochloride Injection Sales by Geographic Region (2018-2023) & (Kg)
Table 26. Global Buprenorphine Hydrochloride Injection Sales Market Share Geographic Region (2018-2023)
Table 27. Global Buprenorphine Hydrochloride Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Buprenorphine Hydrochloride Injection Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Buprenorphine Hydrochloride Injection Sales by Country/Region (2018-2023) & (Kg)
Table 30. Global Buprenorphine Hydrochloride Injection Sales Market Share by Country/Region (2018-2023)
Table 31. Global Buprenorphine Hydrochloride Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Buprenorphine Hydrochloride Injection Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Buprenorphine Hydrochloride Injection Sales by Country (2018-2023) & (Kg)
Table 34. Americas Buprenorphine Hydrochloride Injection Sales Market Share by Country (2018-2023)
Table 35. Americas Buprenorphine Hydrochloride Injection Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Buprenorphine Hydrochloride Injection Revenue Market Share by Country (2018-2023)
Table 37. Americas Buprenorphine Hydrochloride Injection Sales by Type (2018-2023) & (Kg)
Table 38. Americas Buprenorphine Hydrochloride Injection Sales by Application (2018-2023) & (Kg)
Table 39. APAC Buprenorphine Hydrochloride Injection Sales by Region (2018-2023) & (Kg)
Table 40. APAC Buprenorphine Hydrochloride Injection Sales Market Share by Region (2018-2023)
Table 41. APAC Buprenorphine Hydrochloride Injection Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Buprenorphine Hydrochloride Injection Revenue Market Share by Region (2018-2023)
Table 43. APAC Buprenorphine Hydrochloride Injection Sales by Type (2018-2023) & (Kg)
Table 44. APAC Buprenorphine Hydrochloride Injection Sales by Application (2018-2023) & (Kg)
Table 45. Europe Buprenorphine Hydrochloride Injection Sales by Country (2018-2023) & (Kg)
Table 46. Europe Buprenorphine Hydrochloride Injection Sales Market Share by Country (2018-2023)
Table 47. Europe Buprenorphine Hydrochloride Injection Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Buprenorphine Hydrochloride Injection Revenue Market Share by Country (2018-2023)
Table 49. Europe Buprenorphine Hydrochloride Injection Sales by Type (2018-2023) & (Kg)
Table 50. Europe Buprenorphine Hydrochloride Injection Sales by Application (2018-2023) & (Kg)
Table 51. Middle East & Africa Buprenorphine Hydrochloride Injection Sales by Country (2018-2023) & (Kg)
Table 52. Middle East & Africa Buprenorphine Hydrochloride Injection Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Buprenorphine Hydrochloride Injection Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Buprenorphine Hydrochloride Injection Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Buprenorphine Hydrochloride Injection Sales by Type (2018-2023) & (Kg)
Table 56. Middle East & Africa Buprenorphine Hydrochloride Injection Sales by Application (2018-2023) & (Kg)
Table 57. Key Market Drivers & Growth Opportunities of Buprenorphine Hydrochloride Injection
Table 58. Key Market Challenges & Risks of Buprenorphine Hydrochloride Injection
Table 59. Key Industry Trends of Buprenorphine Hydrochloride Injection
Table 60. Buprenorphine Hydrochloride Injection Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Buprenorphine Hydrochloride Injection Distributors List
Table 63. Buprenorphine Hydrochloride Injection Customer List
Table 64. Global Buprenorphine Hydrochloride Injection Sales Forecast by Region (2024-2029) & (Kg)
Table 65. Global Buprenorphine Hydrochloride Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Buprenorphine Hydrochloride Injection Sales Forecast by Country (2024-2029) & (Kg)
Table 67. Americas Buprenorphine Hydrochloride Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Buprenorphine Hydrochloride Injection Sales Forecast by Region (2024-2029) & (Kg)
Table 69. APAC Buprenorphine Hydrochloride Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Buprenorphine Hydrochloride Injection Sales Forecast by Country (2024-2029) & (Kg)
Table 71. Europe Buprenorphine Hydrochloride Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Buprenorphine Hydrochloride Injection Sales Forecast by Country (2024-2029) & (Kg)
Table 73. Middle East & Africa Buprenorphine Hydrochloride Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Buprenorphine Hydrochloride Injection Sales Forecast by Type (2024-2029) & (Kg)
Table 75. Global Buprenorphine Hydrochloride Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Buprenorphine Hydrochloride Injection Sales Forecast by Application (2024-2029) & (Kg)
Table 77. Global Buprenorphine Hydrochloride Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Siegfried Basic Information, Buprenorphine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Siegfried Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
Table 80. Siegfried Buprenorphine Hydrochloride Injection Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 81. Siegfried Main Business
Table 82. Siegfried Latest Developments
Table 83. Sanofi Basic Information, Buprenorphine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
Table 85. Sanofi Buprenorphine Hydrochloride Injection Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. Johnson Matthey Basic Information, Buprenorphine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Johnson Matthey Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
Table 90. Johnson Matthey Buprenorphine Hydrochloride Injection Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 91. Johnson Matthey Main Business
Table 92. Johnson Matthey Latest Developments
Table 93. Mallinckrodt Basic Information, Buprenorphine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Mallinckrodt Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
Table 95. Mallinckrodt Buprenorphine Hydrochloride Injection Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 96. Mallinckrodt Main Business
Table 97. Mallinckrodt Latest Developments
Table 98. Noramco Basic Information, Buprenorphine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Noramco Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
Table 100. Noramco Buprenorphine Hydrochloride Injection Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 101. Noramco Main Business
Table 102. Noramco Latest Developments
Table 103. Unichemlabs Basic Information, Buprenorphine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Unichemlabs Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
Table 105. Unichemlabs Buprenorphine Hydrochloride Injection Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 106. Unichemlabs Main Business
Table 107. Unichemlabs Latest Developments
Table 108. Arevipharma Basic Information, Buprenorphine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Arevipharma Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
Table 110. Arevipharma Buprenorphine Hydrochloride Injection Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 111. Arevipharma Main Business
Table 112. Arevipharma Latest Developments
Table 113. Resonance-labs Basic Information, Buprenorphine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Resonance-labs Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
Table 115. Resonance-labs Buprenorphine Hydrochloride Injection Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 116. Resonance-labs Main Business
Table 117. Resonance-labs Latest Developments
Table 118. Sun Pharma Basic Information, Buprenorphine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Sun Pharma Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
Table 120. Sun Pharma Buprenorphine Hydrochloride Injection Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 121. Sun Pharma Main Business
Table 122. Sun Pharma Latest Developments
Table 123. Rusan Pharma Basic Information, Buprenorphine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Rusan Pharma Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
Table 125. Rusan Pharma Buprenorphine Hydrochloride Injection Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 126. Rusan Pharma Main Business
Table 127. Rusan Pharma Latest Developments
Table 128. Micro Orgo Chem Basic Information, Buprenorphine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Micro Orgo Chem Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
Table 130. Micro Orgo Chem Buprenorphine Hydrochloride Injection Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 131. Micro Orgo Chem Main Business
Table 132. Micro Orgo Chem Latest Developments
Table 133. Faranshimi Basic Information, Buprenorphine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Faranshimi Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
Table 135. Faranshimi Buprenorphine Hydrochloride Injection Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 136. Faranshimi Main Business
Table 137. Faranshimi Latest Developments
Table 138. Teva Basic Information, Buprenorphine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Teva Buprenorphine Hydrochloride Injection Product Portfolios and Specifications
Table 140. Teva Buprenorphine Hydrochloride Injection Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 141. Teva Main Business
Table 142. Teva Latest Developments

LIST OF FIGURES

Figure 1. Picture of Buprenorphine Hydrochloride Injection
Figure 2. Buprenorphine Hydrochloride Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Buprenorphine Hydrochloride Injection Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Buprenorphine Hydrochloride Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Buprenorphine Hydrochloride Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 0.3mg / mL
Figure 10. Product Picture of 0.3mg / mL
Figure 11. Global Buprenorphine Hydrochloride Injection Sales Market Share by Type in 2022
Figure 12. Global Buprenorphine Hydrochloride Injection Revenue Market Share by Type (2018-2023)
Figure 13. Buprenorphine Hydrochloride Injection Consumed in Analgesic
Figure 14. Global Buprenorphine Hydrochloride Injection Market: Analgesic (2018-2023) & (Kg)
Figure 15. Buprenorphine Hydrochloride Injection Consumed in Opioid Antagonist
Figure 16. Global Buprenorphine Hydrochloride Injection Market: Opioid Antagonist (2018-2023) & (Kg)
Figure 17. Global Buprenorphine Hydrochloride Injection Sales Market Share by Application (2022)
Figure 18. Global Buprenorphine Hydrochloride Injection Revenue Market Share by Application in 2022
Figure 19. Buprenorphine Hydrochloride Injection Sales Market by Company in 2022 (Kg)
Figure 20. Global Buprenorphine Hydrochloride Injection Sales Market Share by Company in 2022
Figure 21. Buprenorphine Hydrochloride Injection Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Buprenorphine Hydrochloride Injection Revenue Market Share by Company in 2022
Figure 23. Global Buprenorphine Hydrochloride Injection Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Buprenorphine Hydrochloride Injection Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Buprenorphine Hydrochloride Injection Sales 2018-2023 (Kg)
Figure 26. Americas Buprenorphine Hydrochloride Injection Revenue 2018-2023 ($ Millions)
Figure 27. APAC Buprenorphine Hydrochloride Injection Sales 2018-2023 (Kg)
Figure 28. APAC Buprenorphine Hydrochloride Injection Revenue 2018-2023 ($ Millions)
Figure 29. Europe Buprenorphine Hydrochloride Injection Sales 2018-2023 (Kg)
Figure 30. Europe Buprenorphine Hydrochloride Injection Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Buprenorphine Hydrochloride Injection Sales 2018-2023 (Kg)
Figure 32. Middle East & Africa Buprenorphine Hydrochloride Injection Revenue 2018-2023 ($ Millions)
Figure 33. Americas Buprenorphine Hydrochloride Injection Sales Market Share by Country in 2022
Figure 34. Americas Buprenorphine Hydrochloride Injection Revenue Market Share by Country in 2022
Figure 35. Americas Buprenorphine Hydrochloride Injection Sales Market Share by Type (2018-2023)
Figure 36. Americas Buprenorphine Hydrochloride Injection Sales Market Share by Application (2018-2023)
Figure 37. United States Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Buprenorphine Hydrochloride Injection Sales Market Share by Region in 2022
Figure 42. APAC Buprenorphine Hydrochloride Injection Revenue Market Share by Regions in 2022
Figure 43. APAC Buprenorphine Hydrochloride Injection Sales Market Share by Type (2018-2023)
Figure 44. APAC Buprenorphine Hydrochloride Injection Sales Market Share by Application (2018-2023)
Figure 45. China Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Buprenorphine Hydrochloride Injection Sales Market Share by Country in 2022
Figure 53. Europe Buprenorphine Hydrochloride Injection Revenue Market Share by Country in 2022
Figure 54. Europe Buprenorphine Hydrochloride Injection Sales Market Share by Type (2018-2023)
Figure 55. Europe Buprenorphine Hydrochloride Injection Sales Market Share by Application (2018-2023)
Figure 56. Germany Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Buprenorphine Hydrochloride Injection Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Buprenorphine Hydrochloride Injection Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Buprenorphine Hydrochloride Injection Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Buprenorphine Hydrochloride Injection Sales Market Share by Application (2018-2023)
Figure 65. Egypt Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Buprenorphine Hydrochloride Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Buprenorphine Hydrochloride Injection in 2022
Figure 71. Manufacturing Process Analysis of Buprenorphine Hydrochloride Injection
Figure 72. Industry Chain Structure of Buprenorphine Hydrochloride Injection
Figure 73. Channels of Distribution
Figure 74. Global Buprenorphine Hydrochloride Injection Sales Market Forecast by Region (2024-2029)
Figure 75. Global Buprenorphine Hydrochloride Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Buprenorphine Hydrochloride Injection Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Buprenorphine Hydrochloride Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Buprenorphine Hydrochloride Injection Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Buprenorphine Hydrochloride Injection Revenue Market Share Forecast by Application (2024-2029)


More Publications